CYP2D6 update: Revised nomenclature for CYP2D7/2D6 hybrid genes

Pharmacogenetics and Genomics

Volumn 22, Issue 9, 2012, Pages 692-694

  Sim, Sarah C ^a   Daly, Ann K ^b   Gaedigk, Andrea ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c CHILDREN S MERCY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ALLELE; CYP2D6 GENE; CYP2D7 GENE; EXON; GENE DELETION; GENE INSERTION; GENE REARRANGEMENT; GENETIC VARIABILITY; GENOTYPE; HYBRID GENE; INTRON; LETTER; NOMENCLATURE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PSEUDOGENE; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; CYTOCHROME P-450 CYP2D6; CYTOCHROME P-450 ENZYME SYSTEM; EXONS; GENETIC VARIATION; HUMANS; TERMINOLOGY AS TOPIC;

EID: 84864916868     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e3283546d3c     Document Type: Letter

References (11)

1. Sim SC, Ingelman-Sundberg M. The Human Cytochrome P450 (CYP) Allele Nomenclature website: a peer-reviewed database of CYP variants and their associated effects. Hum Genomics 2010; 4:278-281.
2. Panserat S, Mura C, Gerard N, Vincent-Viry M, Galteau MM, Jacq-Aigrain E, et al. An unequal cross-over event within the CYP2D gene cluster generates a chimeric CYP2D7/CYP2D6 gene which is associated with the poor metabolizer phenotype. Br J Clin Pharmacol 1995; 40:361-367.
3. Daly AK, Fairbrother KS, Andreassen OA, London SJ, Idle JR, Steen VM. Characterization and PCR-based detection of two different hybrid CYP2D7P/CYP2D6 alleles associated with the poor metabolizer phenotype. Pharmacogenetics 1996; 6:319-328.
4. Gaedigk A, Gotschall RR, Forbes NS, Simon SD, Kearns GL, Leeder JS. Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency data. Pharmacogenetics 1999; 9:669-682.
5. Gaedigk A, Coetsee C. The CYP2D6 gene locus in South African Coloureds: unique allele distributions, novel alleles and gene arrangements. Eur J Clin Pharmacol 2008; 64:465-475.
6. Black JL,Walker DL, O'Kane DJ, Harmandayan M. Frequency of undetected CYP2D6 hybrid genes in clinical samples: impact on phenotype prediction. Drug Metab Dispos 2012; 40:111-119.
7. Gaedigk A, Fuhr U, Johnson C, Berard LA, Bradford D, Leeder JS. CYP2D7-2D6 hybrid tandems: identification of novel CYP2D6 duplication arrangements and implications for phenotype prediction. Pharmacogenomics 2010; 11:43-53.
8. Gaedigk A, Jaime LK, Bertino JS Jr, Berard A, Pratt VM, Bradfordand LD, Leeder JS. Identification of novel CYP2D7-2D6 hybrids: non-functional and functional variants. Front Pharmacol 2010; 1:121.
9. Kramer WE,Walker DL, O'Kane DJ, Mrazek DA, Fisher PK, Dukek BA, et al. CYP2D6: novel genomic structures and alleles. Pharmacogenet Genomics 2009; 19:813-822.
10. Gaedigk A, Twist GP, Leeder JS. CYP2D6, SULT1A1 and UGT2B17 copy number variation (CNV): quantitative detection by multiplex PCR. Pharmacogenomics 2012; 13:91-111.
11. Daly AK, Brockmoller J, Broly F, Eichelbaum M, EvansWE, Gonzalez FJ, et al. Nomenclature for human CYP2D6 alleles. Pharmacogenetics 1996; 6: 193-201.